期刊文献+

蛋白激酶CK2α对喉癌细胞凋亡和超微结构的影响 被引量:3

Effects of protein kinase CK2α on apoptosis and ultrastructure of laryngeal carcinoma cells
原文传递
导出
摘要 目的 探讨蛋白激酶CK2α对人喉癌细胞凋亡和超微结构的影响及其可能机制.方法 用脂质体转染法分别将蛋白激酶CK2α特异性siRNA表达质粒psiRNA-hH1neo-CK2α及非特异性siRNA表达质粒psiRNA-hH1neo-cont转染人喉癌Hep-2细胞.Western印迹法检测转染细胞蛋白激酶CK2α蛋白表达,膜联蛋白V-异硫氰酸荧光素(Annexin V-FITC)和碘化丙啶(PI)双染色法检测转染细胞凋亡率的变化,透射电镜观察转染细胞形态学变化,Western印迹法检测转染细胞bcl-2和Bax蛋白的表达.结果 转染psiRNA-hH1neo-CK2α质粒后,Hep-2细胞蛋白激酶CK2α蛋白表达明显下降(P<0.01).和未转染细胞组和psiRNA-hH1neo-cont转染细胞组比较,psiRNA-hH1neo-CK2α转染组细胞出现典型的凋亡征象,如核固缩、染色质凝集靠近核膜和凋亡小体形成.psiRNA-hH1neo-CK2α转染细胞凋亡率明显高于未转染细胞组和psiRNA-hH1neo-cont转染细胞组(25.66%±0.83%比3.66%±0.43%、5.18%±0.22%,均P<0.05);与其他2组比较,psiRNA-hH1neo-CK2α转染组细胞bcl-2蛋白表达较低(相对吸光度比值为0.20±0.09 vs 0.72±0.16、0.56±0.11,均P<0.01),Bax蛋白表达较高(相对吸光度比值为0.81±0.17 vs 0.26±0.12、0.33±0.17,均P<0.01),bcl-2/Bax较低(0.25±0.05 vs 2.76±0.21、1.70±0.22,均P<0.01).结论 蛋白激酶CK2α与喉癌细胞凋亡密切相关,该作用可能与bcl-2/Bax降低有关,蛋白激酶CK2α可能是一个有潜力的喉癌治疗靶点. Objective To investigate the effect of protein kinase CK2α on apoptosis and ultrastructure of human laryngeal carcinoma cells and its possible mechanism. Methods The siRNA expression plasmid psiRNA-hH1neo-CK2αt specific to protein kinase CK2α and non-specific siRNA expression plasmid psiRNA-hH1neo-cont were transfected into Hep-2 cells respectively by lipofectamine method. Western blot was used to detect the expression of kinase CK2α protein. The apoptotic rate was measured by Annexin V-FITC/PI double-staining. The morphological changes of Hep-2 cells were observed under transmission electron microscope ( TEM ). The expressions of bcl-2 and Bax protein were measured by Western blot. Results The expression of protein kinase CK2α protein significantly decreased in the Hep-2 cells transfected with psiRNA-hH1 neo-CK2α( P 〈 0.01 ). Compared with the untransfected cells and siRNA-hH1neo-cont transfected group, psiRNA-hH1neo-CK2α transfected group presented with classical ultrastructural features of apoptosis, such as karyopyknosis, chromatic agglutination adjacent to nuclear membrane and apoptotic body. The apoptotic rate of psiRNA-hH1 neo-CK2α transfected group was obviously higher than that in untransfected cells and siRNA-hH1neo-cont transfected group (25.66% ± 0.83% vs 3.66% ±0.43%, 5.18% ±0.22%, both P 〈 0.05). Compared with two other groups, the bcl-2 protein expression of psiRNA-hH1 neo-CK2α transfected group decreased (0.20 ± 0.09 vs 0.72 ±± 0. 16, 0. 56 ±0.11, both P 〈 0.01 ), the Bax protein expression increased (0.81 ± 0.17 vs 0.26 ± 0. 12, 0.33 ± 0.17,both P 〈 0.01 ) while the ratio of bcl-2 to Bax decreased (0.25 ±0.05 vs 2.76 ±0.21, 1.70 ±0. 22, both P 〈 0.01 ). Conclusion Protein kinase CK2a plays an important role in the apoptosis of human laryngeal carcinoma cells possibly by decreasing bcl-2/Bax. Protein kinase CK2a may provide a potential therapeutic target against human laryngeal carcinoma
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第40期2869-2872,共4页 National Medical Journal of China
关键词 喉肿瘤 细胞凋亡 酪蛋白激酶Ⅱ 基因 BCL-2 BCL-2相关X蛋白质 Laryngeal neoplasms Apoptosis Casein kinase Ⅱ Genes, bcl-2 bcl-2-associated Ⅹ protein
  • 相关文献

参考文献11

  • 1St-Denis NA,Litchfield DW.Protein kinase CK2 in health and disease:from birth to death:the role of protein kinase CK2 in the regulation of cell proliferation and survival.Cell Mol Life Sci,2009,66:1817-1829.
  • 2Ahmed K,Gerber DA,Cochet C.Joining the cell survival squad:an emerging role for protein kinase CK2.Trends Cell Biol,2002,12:226-230.
  • 3Litchfield DW.Protein CK2:structure,regulation and role in celluler decisions of life and death.Biochem J,2003,369:1-15.
  • 4Vilk G,Weber JE,Turowec JP,et al.Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.Cell Signal,2008,20:1942-1951.
  • 5Sarno S,Pinna LA.Protein kinase CK2 as a druggable target Mol Biosyst,2008,4:889-894.
  • 6王建亭,龚树生,刘英鹏.蛋白激酶CK2α在喉鳞状细胞癌组织中的表达及临床意义[J].临床耳鼻咽喉科杂志,2006,20(9):412-414. 被引量:5
  • 7Unger GM,Davis AT,Slaton JW,et al.Protein Kinase CK2 as regulator of cell Survival:implications for cancer therapy.Curr Cancer Drug Targets,2004,4:77-84.
  • 8Trembley JH,Chen Z,Unger G,et al.Emergence of protein kinase CK2 as a key target in cancer therapy.Biofactors,2010,36:187-195.
  • 9Trembley JH,Wang G,Unger G,et al.Protein kinase CK2 in health and disease:CK2:a key player in cancer biology.Cell Mol Life Sci,2009,66:1858-1867.
  • 10Gustafsson AB,Gottlieb RA.Bcl-2 family members and apoptosis,taken to heart.Am J Physiol Cell Physiol,2007,292:G45 -C51.

二级参考文献4

  • 1Channavajhala P, Seldin D C. Functional interaction of protein kinase CK2 and c-Myc inlymphomagenesis. Oncogene, 2002,21:5280-5288.
  • 2Filhol O, Cochet C. Protein kinase CK2 and cancer:further clues are accumulating. Bull Cancer, 2002,89:261-265.
  • 3Unger G M, Davis A T, Slaton J W, et al. Protein kinase CK2 as regulator of cell survival: implication for cancer therapy. Curr Cancer Drug Targets, 2004,4 : 77-84.
  • 4Pinna L A. Protein kinase CK2: a challenge to canons.J Cell Sci, 2002,115:3873-3878.

共引文献4

同被引文献25

  • 1邵世坤,裴福兴,狄东华,赵建忠.关节软骨撞击伤后软骨细胞凋亡的实验研究[J].中国矫形外科杂志,2007,15(10):771-772. 被引量:6
  • 2GOSEKI N,KOIKE M,YOSHIDA M. Histopathologic character-istics of early stage esophageal carcinoma. A comparative studywith gastric carcinoma[ J]. Cancer, 1992,69(5) : 1088 - 1093.
  • 3ROTH J A,PUTNAM J B Jr. Surgery for cancer of the esophagus[J]. Semin Oncol, 1994, 21(4) : 453 -461.
  • 4SCHOPPMANN S F,JESCH B, FRIEDRICH J, et ai. Expressionof Her -2 in carcinomas of the esophagus[ J]. Am J Surg Pathol,2010,34(12) : 1868 -1873.
  • 5DAVID S, MELTZER S J. MicroRNA involvement in esophageal car-cinogenesis[J]. Curr Opin Pharmacol, 2011, 11(6) : 612-616.
  • 6ZHAO H, YANG J, FAN T, et al. RhoE functions as a tumorsuppressor in esophageal squamous cell carcinoma and modulatesthe PTEN/PI3K/Akt signaling pathway[ J]. Tumour Biol, 2012,3(5) : 1363 -1374.
  • 7LITCHFIELD D W. Protein kinase CK2: structure, regulation androle in cellular decisions of life and death[ J]. Biochem J,2003,369(Pt 1) : 1-15.
  • 8AHMED K,GERBER D A, COCHET C. Joining the cell survivalsquad : an emerging role for protein kinase CK2 [ J ]. Trends CellBiol, 2002, 12(5) : 226 -230.
  • 9ST DENIS N A,LITCHFIELD D W. Protein kinase CK2 in healthand disease : From birth to death : the role of protein kinase CK2 inthe regulation of cell proliferation and survival [ J]. Cell Mol LifeSci,2009,66(11/12) : 1817 -1829.
  • 10LANDESMAN BOLLAG E,ROMIEU MOUREZ R,SONG D H’et al. Protein kinase CK2 in mammary gland tumorigenesis[ J].Oncogene, 2001, 20(25) : 3247 -3257.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部